AM-2233: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').
→‎References: Fixed spacing between stub template and category templates.
 
(53 intermediate revisions by 36 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 451603691
| Watchedfields = changed
| IUPAC_name = 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole
| verifiedrevid = 456506144
| IUPAC_name = 1-[(''N''-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole
| image = AM-2233_structure.png
| image = AM-2233_structure.png
| width = 200
| width = 200
Line 11: Line 14:
| pregnancy_category =
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA = Schedule II
| legal_DE = Anlage II
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_UK = Class B
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_NZ = Temporary Class
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =


<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
Line 22: Line 27:
| metabolism =
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =


<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 444912-75-8 -->
| CAS_number = 444912-75-8
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z489688DK3
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 364266
| ChEMBL = 364266
| PubChem = 10226340
| PubChem = 10226340
Line 37: Line 46:
<!--Chemical data-->
<!--Chemical data-->
| C=22 | H=23 | I=1 | N=2 | O=1
| C=22 | H=23 | I=1 | N=2 | O=1
| molecular_weight = 458.334 g/mol
| smiles = Ic3ccccc3C(=O)c1cn(CC2CCCCN2C)c4c1cccc4
| smiles = Ic3ccccc3C(=O)c1cn(CC2CCCCN2C)c4c1cccc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 45: Line 53:
}}
}}


'''AM-2233''' is a drug which acts as a highly potent [[full agonist]] for the [[cannabinoid receptor]]s, with a [[Dissociation constant|K<sub>i</sub>]] of 1.8nM at [[Cannabinoid receptor 1|CB<sub>1</sub>]] and 2.2nM at [[Cannabinoid receptor 2|CB<sub>2</sub>]] as the active (R) [[enantiomer]].<ref>[http://proquest.umi.com/pqdlink?did=726066941&Fmt=7&clientId=79356&RQT=309&VName=PQD Hongfeng Deng. Design and synthesis of selective cannabinoid receptor ligands: Aminoalkylindole and other heterocyclic analogs. PhD Dissertation, University of Connecticut, 2000.]</ref> It was developed as a selective [[isotopic labelling|radioligand]] for the cannabinoid receptors and has been used as its [[Iodine-131|<sup>131</sup>I]] derivative for mapping the distribution of the CB<sub>1</sub> receptor in the brain.<ref name="pmid16190764">{{cite journal |author=Deng H, Gifford AN, Zvonok AM, Cui G, Li X, Fan P, Deschamps JR, Flippen-Anderson JL, Gatley SJ, Makriyannis A |title=Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor |journal=Journal of Medicinal Chemistry |volume=48 |issue=20 |pages=6386–92 |year=2005 |month=October |pmid=16190764 |doi=10.1021/jm050135l |url=}}</ref><ref>{{cite doi|10.1007/3-7643-7358-X_2}}</ref><ref name="pmid16438957">{{cite journal |author=Shen CP, Xiao JC, Armstrong H, Hagmann W, Fong TM |title=F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist |journal=European Journal of Pharmacology |volume=531 |issue=1–3 |pages=41–6 |year=2006 |month=February |pmid=16438957 |doi=10.1016/j.ejphar.2005.12.026 |url=}}</ref><ref>{{cite doi|10.1002/syn.20277}}</ref><ref name="pmid20641836">{{cite journal |author=Leung K |title=R-2-[131I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone |journal=Molecular Imaging and Contrast Agent Database (MICAD) [Internet] |volume= |issue= |pages= |year=2006 Dec 12 |pmid=20641836 |doi= |url=}}</ref><ref>{{cite doi|10.1016/j.chembiol.2008.10.011}}</ref> AM-2233 was found to fully substitute for [[tetrahydrocannabinol|THC]] in rats, with a potency lower than that of [[JWH-018]] but higher than [[WIN 55,212-2]].<ref name="pmid21836461">{{cite journal |author=Järbe TU, Deng H, Vadivel SK, Makriyannis A |title=Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ9-tetrahydrocannabinol) discrimination for rats |journal=Behavioural Pharmacology |volume=22 |issue=5-6 |pages=498–507 |year=2011 |month=September |pmid=21836461 |doi=10.1097/FBP.0b013e328349fbd5 |url=}}</ref>
'''AM-2233''' is a drug that acts as a highly potent [[full agonist]] for the [[cannabinoid receptor]]s, with a [[Dissociation constant|''K''<sub>i</sub>]] of 1.8&nbsp;nM at [[Cannabinoid receptor 1|CB<sub>1</sub>]] and 2.2&nbsp;nM at [[Cannabinoid receptor 2|CB<sub>2</sub>]] as the active (''R'') [[enantiomer]].<ref>{{Cite thesis |type=PhD Dissertation |title=Design and synthesis of selective cannabinoid receptor ligands: Aminoalkylindole and other heterocyclic analogs |author = Hongfeng Deng |year=2000 |publisher=University of Connecticut |id={{ProQuest|304624325}} }}</ref> It was developed as a selective [[isotopic labelling|radioligand]] for the cannabinoid receptors and has been used as its [[Iodine-131|<sup>131</sup>I]] derivative for mapping the distribution of the CB<sub>1</sub> receptor in the brain.<ref name="pmid16190764">{{cite journal | vauthors = Deng H, Gifford AN, Zvonok AM, Cui G, Li X, Fan P, Deschamps JR, Flippen-Anderson JL, Gatley SJ, Makriyannis A | display-authors = 6 | title = Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor | journal = Journal of Medicinal Chemistry | volume = 48 | issue = 20 | pages = 6386–6392 | date = October 2005 | pmid = 16190764 | doi = 10.1021/jm050135l }}</ref><ref>{{Cite book | vauthors = Hanuš LR, Mechoulam R | title = Cannabinoids as Therapeutics | doi = 10.1007/3-7643-7358-X_2 | pages = 23–46 | year = 2005 | chapter = Cannabinoid chemistry: an overview | series = Milestones in Drug Therapy MDT | isbn = 978-3-7643-7055-8 }}</ref><ref name="pmid16438957">{{cite journal | vauthors = Shen CP, Xiao JC, Armstrong H, Hagmann W, Fong TM | title = F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist | journal = European Journal of Pharmacology | volume = 531 | issue = 1–3 | pages = 41–46 | date = February 2006 | pmid = 16438957 | doi = 10.1016/j.ejphar.2005.12.026 }}</ref><ref>{{cite journal | vauthors = Dhawan J, Deng H, Gatley SJ, Makriyannis A, Akinfeleye T, Bruneus M, Dimaio AA, Gifford AN | display-authors = 6 | title = Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233 | journal = Synapse | volume = 60 | issue = 2 | pages = 93–101 | date = August 2006 | pmid = 16715483 | doi = 10.1002/syn.20277 | s2cid = 21269336 | author-link4 = Alexandros Makriyannis }}
</ref><ref name="pmid20641836">{{cite journal | vauthors = Leung K | title = R-2-[131I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone | journal = Molecular Imaging and Contrast Agent Database (MICAD) [Internet] | date = Dec 12, 2006 | pmid = 20641836 }}</ref><ref>{{cite journal | vauthors = Pei Y, Mercier RW, Anday JK, Thakur GA, Zvonok AM, Hurst D, Reggio PH, Janero DR, Makriyannis A | display-authors = 6 | title = Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation | journal = Chemistry & Biology | volume = 15 | issue = 11 | pages = 1207–1219 | date = November 2008 | pmid = 19022181 | pmc = 3700404 | doi = 10.1016/j.chembiol.2008.10.011 }}
</ref> AM-2233 was found to fully substitute for [[tetrahydrocannabinol|THC]] in rats, with a potency lower than that of [[JWH-018]] but higher than [[WIN 55,212-2]].<ref name="pmid21836461">{{cite journal | vauthors = Järbe TU, Deng H, Vadivel SK, Makriyannis A | title = Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats | journal = Behavioural Pharmacology | volume = 22 | issue = 5–6 | pages = 498–507 | date = September 2011 | pmid = 21836461 | pmc = 3212432 | doi = 10.1097/FBP.0b013e328349fbd5 }}</ref>


It is notable for inducing [[tinnitus]],<ref>{{cite web | url=http://hamiltonmorris.blogspot.com/2014/09/am-2233-induced-tinnitus-collected.html | title=AM-2233 INDUCED TINNITUS: COLLECTED REPORTS | date=30 September 2014 | language=en | access-date=5 April 2019}}</ref> though the reasons for this are unclear and may provide valuable insight into tinnitus research.
==See also==

==Legal Status==

As of October 2015 AM-2233 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | access-date=1 October 2015 | archive-url=https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html | archive-date=1 October 2015 | url-status=dead }}</ref>

== See also ==
* [[AM-679 (cannabinoid)|AM-679]]
* [[AM-679 (cannabinoid)|AM-679]]
* [[AM-694]]
* [[AM-694]]
* [[AM-1220]]
* [[AM-1220]]
* [[AM-1221]]
* [[AM-1221]]
* [[AM-1235]]
* [[AM-1241]]
* [[AM-1241]]
* [[AM-2232]]
* [[Cannabipiperidiethanone]]
* [[Cannabipiperidiethanone]]
* [[FUBIMINA]]
* [[JWH-018]]
* [[List of AM cannabinoids]]
* [[List of JWH cannabinoids]]
* [[List of HU cannabinoids]]
* [[List of designer drugs]]


==References==
== References ==
{{reflist}}
<references/>


{{Cannabinoids}}
{{Cannabinoids}}


[[Category:Cannabinoids]]
[[Category:Benzoylindoles]]
[[Category:Benzoylindoles]]
[[Category:AM cannabinoids]]
[[Category:AM cannabinoids]]
[[Category:Aminoalkylindoles]]
[[Category:Aminoalkylindoles]]
[[Category:Organoiodides]]
[[Category:Iodobenzene derivatives]]
[[Category:Piperidines]]
[[Category:Piperidines]]
[[Category:Designer drugs]]